Principal Financial Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.7M | Buy |
|
|||||
|
2025
Q2 | $37.1M | Buy |
|
|||||
|
2025
Q1 | $34.5M | Buy |
|
|||||
|
2024
Q4 | $17.5M | Buy |
|
|||||
|
2024
Q3 | $305K | Sell |
|
|||||
|
2024
Q2 | $528K | Sell |
|
|||||
|
2024
Q1 | $780K | Buy |
|
|||||
|
2023
Q4 | $756K | Buy |
|
|||||
|
2023
Q3 | $655K | Sell |
|
|||||
|
2023
Q2 | $3.13M | Buy |
|
|||||
|
2023
Q1 | $600K | Sell |
|
|||||
|
2022
Q4 | $797K | Buy |
|
|||||
|
2022
Q3 | $385K | Sell |
|
|||||
|
2022
Q2 | $333K | Buy |
|
|||||
|
2022
Q1 | $211K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $244K | Sell |
|
|||||
|
2021
Q2 | $882K | Sell |
|
|||||
|
2021
Q1 | $804K | Sell |
|
|||||
|
2020
Q4 | $1.2M | Buy |
|
|||||
|
2020
Q3 | $820K | Sell |
|
|||||
|
2020
Q2 | $991K | Buy |
|
|||||
|
2020
Q1 | $316K | Sell |
|
|||||
|
2019
Q4 | $777K | Buy |
|